PR Newswire Financial
prCenter
SPRY UPCOMING DEADLINE: SueWallSt Alerts ARS Pharmaceuticals Inc. Stockholders of Securities Class Action - Contact the Firmtranslating…
Allegations focus on ARS Pharmaceuticals' alleged failure to disclose the risk that CVS Caremark's rigid formulary system could push a neffy coverage decision to January 2027, missing the summer and back-to-school allergy seasons. NEW YORK, Sept. 3, 2026 /PRNewswire/ --…
Keywords#ARS#Action#Alerts#Alerts ARS#Alerts ARS Pharmaceuticals
Comments
Sign in to join the discussion.
Loading comments…